{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:12:05Z","timestamp":1791090725030,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072899"],"award-info":[{"award-number":["82072899"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U2004118"],"award-info":[{"award-number":["U2004118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772803"],"award-info":[{"award-number":["81772803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["202300410359"],"award-info":[{"award-number":["202300410359"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2019A1515011100"],"award-info":[{"award-number":["2019A1515011100"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10495-022-01766-5","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T19:02:39Z","timestamp":1661540559000},"page":"946-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Lingfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"6","key":"1766_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3322\/caac.21411","volume":"67","author":"PC Barata","year":"2017","unstructured":"Barata PC, Rini BI (2017) Treatment of renal cell carcinoma: current status and future directions. CA Cancer J Clin 67(6):507\u2013524","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1766_CR2","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley JR et al (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37(10):1469\u20131489","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"1766_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1084\/jem.20181617","volume":"215","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Swanton C, Boshoff C (2018) Kidney cancer: the next decade. J Exp Med 215(10):2477\u20132479","journal-title":"J Exp Med"},{"issue":"11","key":"1766_CR4","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/annonc\/mdu445","volume":"25","author":"TK Choueiri","year":"2014","unstructured":"Choueiri TK et al (2014) PD-L1 expression in nonclear-cell renal cell carcinoma. Ann Oncol 25(11):2178\u20132184","journal-title":"Ann Oncol"},{"issue":"6","key":"1766_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ccell.2020.10.011","volume":"38","author":"RJ Motzer","year":"2020","unstructured":"Motzer RJ et al (2020) Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade. Cancer Cell 38(6):803-817.e4","journal-title":"Cancer Cell"},{"issue":"12","key":"1766_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1056\/NEJMoa1816714","volume":"380","author":"BI Rini","year":"2019","unstructured":"Rini BI et al (2019) Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med 380(12):1116\u20131127","journal-title":"N Engl J Med"},{"issue":"1","key":"1766_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.critrevonc.2015.05.008","volume":"96","author":"G Courthod","year":"2015","unstructured":"Courthod G et al (2015) Papillary renal cell carcinoma: a review of the current therapeutic landscape. Crit Rev Oncol Hematol 96(1):100\u2013112","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"1766_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X et al (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280\u2013296","journal-title":"Nat Rev Clin Oncol"},{"issue":"1\u20132","key":"1766_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"issue":"2","key":"1766_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88","journal-title":"Cell Death Dis"},{"issue":"40","key":"1766_CR11","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess H et al (2018) The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37(40):5435\u20135450","journal-title":"Oncogene"},{"issue":"1","key":"1766_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y et al (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34","journal-title":"J Hematol Oncol"},{"issue":"7755","key":"1766_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W et al (2019) CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569(7755):270\u2013274","journal-title":"Nature"},{"issue":"10189","key":"1766_CR14","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/S0140-6736(19)30723-8","volume":"393","author":"BI Rini","year":"2019","unstructured":"Rini BI et al (2019) Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Lancet 393(10189):2404\u20132415","journal-title":"Lancet"},{"key":"1766_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa021","author":"N Zhou","year":"2020","unstructured":"Zhou N, Bao J (2020) FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford). https:\/\/doi.org\/10.1093\/database\/baaa021","journal-title":"Database (Oxford)"},{"issue":"12","key":"1766_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550","journal-title":"Genome Biol"},{"issue":"W1","key":"1766_CR17","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z et al (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45(W1):W98\u2013W102","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"1766_CR18","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ et al (2015) The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 21(8):938\u2013945","journal-title":"Nat Med"},{"issue":"1","key":"1766_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18(1):220","journal-title":"Genome Biol"},{"issue":"1","key":"1766_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P et al (2017) Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep 18(1):248\u2013262","journal-title":"Cell Rep"},{"issue":"23","key":"1766_CR21","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L et al (2018) TIP: a web server for resolving tumor immunophenotype profiling. Cancer Res 78(23):6575\u20136580","journal-title":"Cancer Res"},{"issue":"10","key":"1766_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24(10):1550\u20131558","journal-title":"Nat Med"},{"issue":"7860","key":"1766_CR23","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C et al (2021) DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593(7860):586\u2013590","journal-title":"Nature"},{"issue":"1","key":"1766_CR24","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","volume":"9","author":"Q Jia","year":"2018","unstructured":"Jia Q et al (2018) Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun 9(1):5361","journal-title":"Nat Commun"},{"issue":"3","key":"1766_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.20091918","volume":"207","author":"SA Quezada","year":"2010","unstructured":"Quezada SA et al (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med 207(3):637\u2013650","journal-title":"J Exp Med"},{"issue":"1","key":"1766_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39(1):1\u201310","journal-title":"Immunity"},{"issue":"1","key":"1766_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X et al (2021) Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 20(1):131","journal-title":"Mol Cancer"},{"issue":"2","key":"1766_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99\u2013115","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1766_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C et al (2021) Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer 20(1):154","journal-title":"Mol Cancer"},{"key":"1766_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc8346","author":"L Li","year":"2021","unstructured":"Li L et al (2021) Laminin gamma2-mediating T cell exclusion attenuates response to anti-PD-1 therapy. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abc8346","journal-title":"Sci Adv"},{"issue":"1","key":"1766_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","volume":"39","author":"GT Motz","year":"2013","unstructured":"Motz GT, Coukos G (2013) Deciphering and reversing tumor immune suppression. Immunity 39(1):61\u201373","journal-title":"Immunity"},{"issue":"15","key":"1766_CR32","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1158\/1078-0432.CCR-12-3847","volume":"19","author":"R Remark","year":"2013","unstructured":"Remark R et al (2013) Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin Cancer Res 19(15):4079\u20134091","journal-title":"Clin Cancer Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-022-01766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-022-01766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-022-01766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T06:20:03Z","timestamp":1667024403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-022-01766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":32,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1007\/s10495-022-01766-5","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"13 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agreed with the content of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}